Panca Budi Idaman Tbk PT
IDX:PBID
Panca Budi Idaman Tbk PT
IDX:PBID
Price:
490
IDR
Market Cap:
3.7T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PBID Alert
Panca Budi Idaman Tbk PT
490
0 (0%)
| 52 Week Range |
474
575
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Panca Budi Idaman Tbk PT
Panca Budi Idaman Tbk PT
| Current Assets | 1.9T |
| Cash & Short-Term Investments | 276B |
| Receivables | 372.7B |
| Other Current Assets | 1.2T |
| Non-Current Assets | 1.4T |
| Long-Term Investments | 148.8B |
| PP&E | 1.2T |
| Intangibles | 26B |
| Other Non-Current Assets | 15.8B |
| Current Liabilities | 327.1B |
| Accounts Payable | 141.5B |
| Accrued Liabilities | 41.6B |
| Short-Term Debt | 68.3B |
| Other Current Liabilities | 75.7B |
| Non-Current Liabilities | 145.4B |
| Long-Term Debt | 38.6B |
| Other Non-Current Liabilities | 106.9B |
Balance Sheet
Panca Budi Idaman Tbk PT
Panca Budi Idaman Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
36 842
|
13 377
|
16 666
|
13 986
|
21 293
|
151 876
|
104 286
|
171 412
|
263 030
|
362 521
|
121 125
|
|
| Cash |
36 842
|
13 377
|
16 666
|
13 986
|
21 293
|
151 876
|
104 286
|
65 412
|
143 530
|
218 521
|
72 655
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
106 000
|
119 500
|
144 000
|
48 470
|
|
| Short-Term Investments |
0
|
2 500
|
5 245
|
305 000
|
188 200
|
242 000
|
389 218
|
70 102
|
40 000
|
16 349
|
451 224
|
|
| Total Receivables |
229 543
|
267 160
|
222 592
|
281 786
|
339 073
|
310 171
|
272 665
|
330 152
|
343 065
|
366 157
|
400 821
|
|
| Accounts Receivables |
175 048
|
214 723
|
212 014
|
273 000
|
334 513
|
304 727
|
264 927
|
324 587
|
339 010
|
360 454
|
394 680
|
|
| Other Receivables |
54 495
|
52 437
|
10 578
|
8 786
|
4 560
|
5 444
|
7 738
|
5 566
|
4 055
|
5 703
|
6 140
|
|
| Inventory |
282 451
|
346 136
|
372 350
|
464 073
|
962 256
|
739 924
|
612 603
|
960 255
|
1 104 811
|
1 043 523
|
1 143 149
|
|
| Other Current Assets |
65 152
|
78 440
|
107 020
|
112 591
|
179 071
|
106 127
|
108 196
|
81 212
|
105 427
|
99 737
|
82 621
|
|
| Total Current Assets |
613 989
|
707 613
|
723 873
|
1 177 436
|
1 689 893
|
1 550 098
|
1 486 968
|
1 613 133
|
1 856 334
|
1 888 286
|
2 198 939
|
|
| PP&E Net |
159 232
|
161 481
|
564 173
|
576 585
|
543 173
|
646 162
|
736 343
|
1 017 328
|
1 061 753
|
1 093 887
|
1 246 037
|
|
| PP&E Gross |
159 232
|
161 481
|
564 173
|
576 585
|
543 173
|
646 162
|
736 343
|
1 017 328
|
1 061 753
|
1 093 887
|
1 246 037
|
|
| Accumulated Depreciation |
40 314
|
48 620
|
37 911
|
58 045
|
80 193
|
105 969
|
154 145
|
93 002
|
133 234
|
182 219
|
126 556
|
|
| Intangible Assets |
61
|
114
|
35 337
|
33 424
|
31 591
|
29 965
|
28 145
|
26 269
|
24 400
|
26 859
|
27 243
|
|
| Note Receivable |
74 255
|
41 301
|
207
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
5 602
|
1 575
|
1 548
|
1 521
|
19 096
|
64 697
|
129 526
|
109 365
|
61 145
|
151 974
|
98 613
|
|
| Other Long-Term Assets |
9 146
|
9 426
|
28 124
|
29 928
|
11 972
|
47 998
|
40 318
|
35 092
|
36 731
|
35 347
|
12 668
|
|
| Total Assets |
862 284
N/A
|
921 511
+7%
|
1 353 263
+47%
|
1 818 905
+34%
|
2 295 735
+26%
|
2 338 920
+2%
|
2 421 301
+4%
|
2 801 187
+16%
|
3 040 363
+9%
|
3 196 353
+5%
|
3 583 499
+12%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
324 318
|
266 056
|
177 185
|
216 253
|
274 759
|
260 498
|
134 109
|
159 771
|
142 381
|
177 343
|
181 005
|
|
| Accrued Liabilities |
8 156
|
7 598
|
15 656
|
24 778
|
25 401
|
27 960
|
40 016
|
48 269
|
45 270
|
53 086
|
69 189
|
|
| Short-Term Debt |
335 895
|
384 292
|
253 531
|
129 438
|
344 759
|
229 254
|
83 326
|
93 681
|
211 208
|
150 333
|
140 783
|
|
| Current Portion of Long-Term Debt |
13 569
|
15 103
|
10 840
|
9 393
|
1 937
|
5 809
|
10 899
|
9 437
|
10 573
|
9 780
|
7 513
|
|
| Other Current Liabilities |
14 604
|
17 392
|
47 683
|
62 366
|
61 454
|
71 215
|
125 989
|
115 991
|
82 800
|
68 643
|
101 752
|
|
| Total Current Liabilities |
696 541
|
690 441
|
504 896
|
442 229
|
708 309
|
594 735
|
394 338
|
427 149
|
492 231
|
459 184
|
500 243
|
|
| Long-Term Debt |
9 769
|
34 383
|
24 198
|
16 494
|
1 630
|
16 525
|
27 467
|
16 242
|
41 737
|
38 497
|
36 050
|
|
| Deferred Income Tax |
1 054
|
1 391
|
2 297
|
229
|
347
|
0
|
0
|
0
|
0
|
0
|
11 441
|
|
| Minority Interest |
1 651
|
6 114
|
20 138
|
22 941
|
25 010
|
5 688
|
6 119
|
6 486
|
7 209
|
6 868
|
7 844
|
|
| Other Liabilities |
25 767
|
22 282
|
30 431
|
40 038
|
41 311
|
59 434
|
70 686
|
80 718
|
60 368
|
68 147
|
75 633
|
|
| Total Liabilities |
734 782
N/A
|
754 612
+3%
|
581 959
-23%
|
521 931
-10%
|
776 608
+49%
|
676 383
-13%
|
498 611
-26%
|
530 594
+6%
|
601 545
+13%
|
572 697
-5%
|
631 211
+10%
|
|
| Equity | ||||||||||||
| Common Stock |
20 000
|
40 000
|
150 000
|
187 500
|
187 500
|
187 500
|
187 500
|
187 500
|
187 500
|
187 500
|
187 500
|
|
| Retained Earnings |
10 091
|
22 697
|
158 810
|
486 260
|
748 355
|
903 656
|
1 172 358
|
1 405 109
|
1 583 603
|
1 780 644
|
1 969 226
|
|
| Additional Paid In Capital |
94 797
|
99 585
|
114 318
|
267 715
|
267 715
|
267 715
|
267 715
|
267 715
|
267 715
|
267 715
|
267 715
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
345 160
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
2 614
|
4 618
|
3 015
|
355 499
|
315 558
|
303 666
|
295 117
|
410 270
|
400 000
|
387 798
|
527 848
|
|
| Total Equity |
127 502
N/A
|
166 899
+31%
|
771 304
+362%
|
1 296 974
+68%
|
1 519 127
+17%
|
1 662 537
+9%
|
1 922 690
+16%
|
2 270 593
+18%
|
2 438 818
+7%
|
2 623 656
+8%
|
2 952 288
+13%
|
|
| Total Liabilities & Equity |
862 284
N/A
|
921 511
+7%
|
1 353 263
+47%
|
1 818 905
+34%
|
2 295 735
+26%
|
2 338 920
+2%
|
2 421 301
+4%
|
2 801 187
+16%
|
3 040 363
+9%
|
3 196 353
+5%
|
3 583 499
+12%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
200
|
400
|
1 500
|
1 875
|
1 875
|
1 875
|
1 875
|
7 500
|
7 500
|
7 500
|
7 500
|
|
Switch to:
Switch to:
See Also
Discover More
